Biotech

All Articles

ReNeuron leaving goal substitution after skipping fundraising goal

.ReNeuron has actually joined the long list of biotechs to leave behind Greater london's purpose sto...

MBX apply for IPO to take opposition to Ascendis right into phase 3

.MBX Biosciences has actually included in the recent outbreak of IPO filings. The biotech, which sub...

FDA expands probing into Lykos' MDMA tests: WSJ

.For Lykos Rehabs and the company's potential MDMA-assisted treatment for trauma (PTSD), the favorit...

Gene publisher Volume giving up 131 workers

.Only days after gene publisher Tome Biosciences declared undisclosed working cuts, a more clear pho...

Repare gives up 25% of staff as biotech stops preclinical R&ampD

.Repare Therapeutics is giving up a quarter of its staff as the oncology biotech scales back its own...

J &amp J files for FDA confirmation of $6.5 B autoimmune medicine

.Johnson &amp Johnson has actually taken an additional action toward recognizing a return on its own...

Gain's period 1 gain leads method to prove Parkinson's drug's worth

.Gain Rehabs has actually established its own direct proving the performance of its own Parkinson's ...

Actinogen documents brand new phase 2 data to salvage depression medicine

.Actinogen Medical's hopes-- and stock price-- have rebounded slightly coming from previously this m...

Pfizer and Front runner include Ratio to multibillion-dollar formula

.Flagship Pioneering and Pfizer have actually incorporated Ratio right into their 10-program allianc...

Bayer markers $547M contract to push perimeters of noncoding RNA

.Bayer execs were eager to worry to Strong this summertime that the German pharma giant's hunger for...